Search results
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 1 day agoThe targeted CD markets are highly competitive. If approved, Lilly will face stiff competition from...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WKBN 27 Youngstown· 7 days ago...presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)- Data to be presented from the SEQUENCE head-to-head trial comparing risankizumab (SKYRIZI®) versus ustekinumab (STELARA®) in Crohn's...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 1 day agoThe company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including ...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 13 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 3 days agoU.S. sales of Humira plummeted by 39.9% year over year in the first quarter to $1.8 billion....
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie...
Benzinga· 6 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target....
NBC's 'SNL' 50th Anniversary Season Signs 4 Presenting Sponsors
MediaPost· 3 days agoNBC has inked four season-long "presenting sponsors" for the 50th anniversary season of longtime weekend late-night show "Saturday Night Live."
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 3 days agoThe board will seek public comments, additional information and data over the next 60 days to...
7 Value Stocks to Buy and Hold for a Decade of Dominance
InvestorPlace via Yahoo Finance· 7 days agoFinding equities with the potential for steady, long-term development is crucial. These seven...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 3 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...